OraSure Technologies to Participate at the Fifth Annual JMP Securities Healthcare Conference
22 Settembre 2010 - 9:41PM
OraSure Technologies, Inc. (Nasdaq:OSUR) today announced that
Douglas A. Michels, President and Chief Executive Officer, will
speak to the investment community at the Fifth Annual JMP
Securities Healthcare Conference in New York City at approximately
3:30pm Eastern Time, (12:30pm Pacific Time) on Tuesday, September
28, 2010. The conference will be simultaneously webcast over the
Internet.
Interested investors can access the live audio webcast of the
discussion by going to OraSure Technologies' web site,
www.orasure.com, and clicking on the Investor Information link. A
replay of the audio webcast will be available until October 5,
2010, on OraSure Technologies' web site.
About OraSure Technologies
OraSure Technologies develops, manufactures and markets oral
fluid specimen collection devices using proprietary oral fluid
technologies, diagnostic products including immunoassays and other
in vitro diagnostic tests, and other medical devices. These
products are sold in the United States as well as internationally
to various clinical laboratories, hospitals, clinics,
community-based organizations and other public health
organizations, distributors, government agencies, physicians'
offices, and commercial and industrial entities.
For more information on the Company, please go to
www.orasure.com.
The OraSure Technologies, Inc. logo is available at
http://www.globenewswire.com/newsroom/prs/?pkgid=6440
CONTACT: OraSure Technologies, Inc.
Ronald H. Spair, Chief Financial Officer
610-882-1820
Investorinfo@orasure.com
www.orasure.com
Grafico Azioni OraSure Technologies (NASDAQ:OSUR)
Storico
Da Giu 2024 a Lug 2024
Grafico Azioni OraSure Technologies (NASDAQ:OSUR)
Storico
Da Lug 2023 a Lug 2024